menu
    • menu
    [{"orgOrder":0,"company":"Asymchem Laboratories","sponsor":"AzurRx BioPharma","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"","productType":"Large molecule","year":"2020","type":"Partnership","leadProduct":"MS1819","moa":"","graph1":"Endocrinology","graph2":"Phase II","graph3":"Asymchem Laboratories","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Asymchem Laboratories \/ AzurRx BioPharma","highestDevelopmentStatusID":"8","companyTruncated":"Asymchem Laboratories \/ AzurRx BioPharma"},{"orgOrder":0,"company":"Asymchem Laboratories","sponsor":"LaNova","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"","productType":"Large molecule","year":"2021","type":"Partnership","leadProduct":"Antibody-drug Conjugates","moa":"","graph1":"Oncology","graph2":"Undisclosed","graph3":"Asymchem Laboratories","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"","sponsorNew":"Asymchem Laboratories \/ LaNova","highestDevelopmentStatusID":"1","companyTruncated":"Asymchem Laboratories \/ LaNova"},{"orgOrder":0,"company":"Asymchem Laboratories","sponsor":"AUM Biosciences","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"","productType":"Small molecule","year":"2022","type":"Collaboration","leadProduct":"AUM601","moa":"","graph1":"Oncology","graph2":"Phase I","graph3":"Asymchem Laboratories","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Oral","sponsorNew":"Asymchem Laboratories \/ Asymchem","highestDevelopmentStatusID":"6","companyTruncated":"Asymchem Laboratories \/ Asymchem"}]

    Find Clinical Drug Pipeline Developments & Deals by Asymchem Laboratories

    Menu

    Asymchem Laboratories

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    SERVICES

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Asymchem Laboratories

                            U.S.A arrow
                            Fi Europe 2024
                            Not Confirmed

                            Asymchem Laboratories

                            U.S.A arrow
                            Fi Europe 2024
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : AUM601

                            Therapeutic Area : Oncology

                            Study Phase : Phase I

                            Recipient : AUM Biosciences

                            Deal Size : Undisclosed

                            Deal Type : Collaboration

                            DEALS_DEV arrow-down

                            AUM Biosciences Identifies Asymchem as the CDMO Partner of Choice for their Novel TRK inhibitor

                            Details : Under the terms of the agreement, AUM and Asymchem agree to collaborate on the process development, and the clinical and commercial production, of AUM 601, which is a highly selective oral small-molecule inhibitor of the tropomyosin receptor kinase for t...

                            Brand Name : AUM601

                            Molecule Type : Small molecule

                            Upfront Cash : Undisclosed

                            January 11, 2022

                            Lead Product(s) : AUM601

                            Therapeutic Area : Oncology

                            Highest Development Status : Phase I

                            Recipient : AUM Biosciences

                            Deal Size : Undisclosed

                            Deal Type : Collaboration

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Asymchem Laboratories

                            U.S.A arrow
                            Fi Europe 2024
                            Not Confirmed

                            Asymchem Laboratories

                            U.S.A arrow
                            Fi Europe 2024
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Antibody-drug Conjugates

                            Therapeutic Area : Oncology

                            Study Phase : Undisclosed

                            Sponsor : LaNova

                            Deal Size : Undisclosed

                            Deal Type : Partnership

                            DEALS_DEV arrow-down

                            Asymchem and LaNova Medicines Enter into Partnership Agreement, Expanding Biological Capabilities

                            Details : The partnership between Asymchem and LaNova will include small molecule drugs, monoclonal antibodies, double antibodies, ADC projects and potentially other R&D and production initiatives.

                            Brand Name : Undisclosed

                            Molecule Type : Large molecule

                            Upfront Cash : Undisclosed

                            September 16, 2021

                            Lead Product(s) : Antibody-drug Conjugates

                            Therapeutic Area : Oncology

                            Highest Development Status : Undisclosed

                            Sponsor : LaNova

                            Deal Size : Undisclosed

                            Deal Type : Partnership

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Asymchem Laboratories

                            U.S.A arrow
                            Fi Europe 2024
                            Not Confirmed

                            Asymchem Laboratories

                            U.S.A arrow
                            Fi Europe 2024
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : MS1819,Porcine enzyme replacement therapy

                            Therapeutic Area : Endocrinology

                            Study Phase : Phase II

                            Sponsor : AzurRx BioPharma

                            Deal Size : Undisclosed

                            Deal Type : Partnership

                            DEALS_DEV arrow-down

                            AzurRx BioPharma Identifies Asymchem as Potential Partner of Choice for MS1819 Phase 3 Clinical Trial Drug Pro...

                            Details : Under the terms of the agreement, Asymchem will implement fermentation, verify protein expression and ultimately fine-tune the technology suitable for production of MS1819.

                            Brand Name : MS1819

                            Molecule Type : Large molecule

                            Upfront Cash : Undisclosed

                            November 10, 2020

                            Lead Product(s) : MS1819,Porcine enzyme replacement therapy

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Phase II

                            Sponsor : AzurRx BioPharma

                            Deal Size : Undisclosed

                            Deal Type : Partnership

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth